| Financial Year |
March 31 2023 |
| Monetary Funds |
1,043,293,007.77 |
| Held-for-trading Financial Assets |
225,631,054.61 |
| Notes Receivable |
779,398,387.66 |
| Accounts Receivable |
560,007,451.23 |
| Advances to Suppliers |
77,864,687.61 |
| Other Receivables |
11,917,496.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
482,713,262.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
158,580,821.92 |
| Other Current Assets |
20,293,028.61 |
| Total Current Assets |
3,359,699,198.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,625,626.81 |
| Investment Properties |
26,162,477.96 |
| Fixed Assetes |
568,814,463.24 |
| Under-construction Projects |
82,251,674.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
454,739,105.06 |
| R&D expenses |
436,030,724.72 |
| Goodwill |
208,626,197.09 |
| Long-Term Deferred and Prepaid Expenses |
5,275,963.23 |
| Deferred Income Tax Assets |
52,211,476.81 |
| Other Non-Current Assets |
386,081,761.79 |
| Sub-Total of Non-Current Assets |
2,387,445,635.31 |
| Total Assets |
5,747,144,833.70 |
| Short-Term Loans |
491,906,897.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,532,228.00 |
| Accounts Payable |
123,450,910.29 |
| Accounts Received In Advance |
4,195.03 |
| Employee Compensation Payable |
19,711,152.81 |
| Taxes Payable |
57,333,864.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
209,128,271.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,434,971.77 |
| Other Current Liabilities |
18,570,903.05 |
| Sub-Total of Current Liabilities |
995,548,662.83 |
| Long-term Loans |
97,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
555,078,412.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
69,273,405.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
786,276,513.26 |
| Total Liabilities |
1,781,825,176.09 |
| Paid-In Capital(Or Share Stock) |
814,431,076.00 |
| Capital Surplus |
1,263,039,904.28 |
| Surplus Reserve |
303,138,449.88 |
| LESS:Treasury Stock |
80,360,172.71 |
| Undistributed Profits |
1,440,371,516.11 |
| Minority Stockholder's Interest |
169,383,893.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,795,935,764.27 |
| Owner's Equity（Stockholder's Equity） |
3,965,319,657.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,747,144,833.70 |
